ArticleBritish journal of haematology2026
Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia.
Catherine Gutierrez Moore et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.